

Founded on the belief that immunotherapy made from a patient’s own cells holds the key to the future of cancer care, Dendreon is making the battle against cancer personal. We are focused on improving the lives of men living with prostate cancer through the delivery of innovative immunotherapies that harness the power of the body’s immune system to extend life. We’re looking for talented people to join our team that will positively impact the lives of patients. Headquartered in Seal Beach, CA, and with sizable locations in Union City, GA and Seattle, WA, as well as a countrywide Commercial team, we have a diverse offering of exciting opportunities. Backed by Cenbest and Sanpower, multi-national conglomerates, we are well-positioned for transformation and growth. Among its major competitors, Dendreon Pharmaceuticals LLC is ranked in 7th place for NPS while Novartis Pharmaceuticals is 1st, and Gilead Sciences is 2nd.
Dendreon Pharmaceuticals LLC's Net Promoter Score (NPS) is a -100 with 0% Promoters, 0% Passives, and 100% Detractors. Net Promoter Score tracks whether Dendreon Pharmaceuticals LLC's customers would recommend using the product based on a scale of -100 to 100.
| 0% | Promoters |
|---|---|
| 0% | Passives |
| 100% | Detractors |
| Summary | Date | Score |
|---|---|---|
Nov 2023 -100 | Nov 2023 | -100 |
Dendreon Pharmaceuticals LLC is ranked #4 for NPS among its competitors. Novartis Pharmaceuticals and Gilead Sciences come in first and second, with Poseida Therapeutics coming in at third.
![]() Dendreon Pharmaceuticals LLC | ![]() Gilead Sciences | ![]() Novartis Pharmaceuticals | ![]() Poseida Therapeutics | |
| Global Ranking | #- | #478 | #599 | #- |
| NPS | -100 | 20 | 23 | -100 |
| Valuation Updated every 24 hours for public companies | - | $83.65B | - | $600.00M |
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, Dendreon Pharmaceuticals LLC's NPS is rated right below Poseida Therapeutics.
Dendreon Pharmaceuticals LLC has a 4.2/5 stars for its overall company culture rated by their employees

In the Top 35% of Similar Sized Companies on Comparably.
Dendreon Pharmaceuticals LLC scored a -100 for Net Promoter Score and a 34 for Employee Net Promoter Score. NPS gauges how likely a customer of Dendreon Pharmaceuticals LLC would recommend the brand to a friend. ENPS measures how likely Dendreon Pharmaceuticals LLC employees would recommend working at Dendreon Pharmaceuticals LLC to a friend.
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 100% | Detractors |
| 67% | Promoters |
|---|---|
| 0% | Passive |
| 33% | Detractors |